Heart Rate Variability during Periods of Low Blood Pressure as a
  Predictor of Short-Term Outcome in Preterms by Semenova, Oksana et al.
  
1Abstract—Efficient management of low blood pressure (BP) 
in preterm neonates remains challenging with a considerable 
variability in clinical practice. The ability to assess preterm 
wellbeing during episodes of low BP will help to decide when and 
whether hypotension treatment should be initiated. This work 
aims to investigate the relationship between heart rate 
variability (HRV), BP and the short-term neurological outcome 
in preterm infants less than 32 weeks gestational age (GA). The 
predictive power of common HRV features with respect to the 
outcome is assessed and shown to improve when HRV is 
observed during episodes of low mean arterial pressure (MAP) - 
with a single best feature leading to an AUC of 0.87. Combining 
multiple features with a boosted decision tree classifier achieves 
an AUC of 0.97. The work presents a promising step towards the 
use of multimodal data in building an objective decision support 
tool for clinical prediction of short-term outcome in preterms 
who suffer episodes of low BP. 
I. INTRODUCTION 
Preterm birth is a leading cause of neonatal mortality. 
Every year more than one in ten babies are born preterm and 
this number is rising [1]. Preterm babies are at a higher risk of 
complications, which may lead to short-term and long-term 
adverse health outcomes. Low blood pressure (BP) or 
hypotension is known to be one of main problems in preterms 
particularly during the first 72 hours after delivery. It may 
cause inadequate blood flow to the brain, heart and other vital 
organs. The definition of hypotension is still uncertain and 
management of preterm neonates with low BP remains 
challenging with significant variability in practice [2]. When 
the level of mean arterial pressure (MAP) falls below the 
gestational age (GA) in weeks, intervention in the form of 
blood volume expansion is commonly initiated. This 
threshold, however, lacks any published supporting evidence. 
At the same time hypotension treatment has been associated 
with adverse outcomes including brain injury [3]. For babies 
with no clinical or biochemical signs of shock, no intervention 
may well be appropriate. 
The ability to assess preterm wellbeing during episodes of 
low BP may improve efficiency of hypotension management. 
ECG is routinely recorded in preterms from which the time 
variation between successive heartbeats (heart rate variability, 
HRV) can be estimated. HRV provides a non-invasive 
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assessment of both the parasympathetic and sympathetic 
control of heart rate. 
In term neonates, a significant association between HRV 
features, severity of hypoxic ischemic brain injury and long-
term neurodevelopmental outcome at two years of age was 
reported for 61 full-term neonates in [4]. Promising results 
have been obtained for newborn outcome prediction using a 
combination of multimodal features including HRV [5]. In 
preterms, the high frequency component of HRV was shown 
to be a good biomarker of necrotizing enterocolitis, an acute 
neonatal inflammatory disease which may lead to death [6]. 
HRV features together with quantification of general physical 
movements have also been found useful for 2-year outcome 
prediction in [7]. In [8], time-domain HRV measurements 
have showed a significant difference between septic and non-
septic newborns. Decreased HRV was observed in children 
born with low birth weight, including preterm babies [9]. 
Measurements of HRV have been assessed as a predictor for 
successful removal of mechanical ventilation in [10]. A 
correlation between low frequency oscillations of HRV and 
BP for preterm neonates has been reported in [11]. 
While several works have tried to study an association 
between HRV and neonatal health outcome in the term and 
preterm population, there is still a lack of understanding of 
this relationship for preterms in the context of low BP 
episodes. 
This study aims to investigate the relationship between 
HRV, BP and the short-term neurological outcome in preterm 
infants who were less than 32 weeks GA. In particular, the 
usefulness of HRV for the prediction of outcome is assessed 
and the predictive power of HRV features during the episodes 
of low BP is studied. 
II. MATERIALS AND METHODS 
A. Dataset 
The dataset is comprised of 35 preterm infants with mean 
GA of 28 weeks (range: 23 – 31 weeks) recorded at the 
Neonatal Intensive Care Unit of Cork University Maternity 
Hospital, Ireland. 
The aim of this study is to investigate the effect of low BP 
on the preterm wellbeing and the threshold was chosen to be 
quite loose, GA+4 (as compared to GA). Twenty three 
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preterm neonates were selected out of 35 (mean GA is 27 
weeks) based on the criteria that during the recording there 
was at least one episode of at least 5 min duration where MAP 
fell below a threshold (MAP < GA +4). The data set included 
continuous ECG and simultaneous registration of BP. The 
total duration of the 23 recordings is 824 hours. A 
ViasysNicOne video EEG machine (CareFusion Co., San 
Diego, USA) was used to record ECG sampled at either 256 
Hz or 1024 Hz. Continuous invasive arterial BP monitoring 
was simultaneously performed via an umbilical arterial 
catheter using the Philips Intellevue MP70 machine, which 
provides BP data sampled at 1 Hz. Positioning of the tip of 
the umbilical catheter in the descending aorta was confirmed 
by chest radiograph. 
Short-term neurological outcome of the preterm was 
represented by clinical course score (CCS) which was 
assigned independently to every infant by two consultant 
neonatologists [12]. CCS is a binary score, which is based on 
the discharge summary and medical notes summarising the 
presence or absence of five major neonatal complications: 
grade III/IV intraventricular haemorrhage or cystic 
periventricular leukomalacia, necrotizing enterocolitis, 
bronchopulmonary dysplasia, infection and retinopathy. The 
study had full ethical approval from the Clinical Research 
Ethics Committee of the Cork Teaching Hospitals. In the 
cohort of 23 preterms, 12 had healthy outcome. 
B. Signal processing and feature extraction 
The diastolic (DP) and systolic (SP) pressures were 
recorded every second and used to calculate the mean arterial 
pressure: 𝑀𝐴𝑃 = 𝐷𝑃 + 1/3 (𝑆𝑃 − 𝐷𝑃). 
The ECG signal was segmented into non-overlapping 5-
minute epochs. The R-peaks were identified using the Pan-
Tompkins method [13]. Abnormal values of time intervals 
between R-peaks (RR intervals) caused by artefacts were 
corrected by moving average where possible. Periods of clear 
movement artefact were automatically discarded. The RR 
intervals were used to estimate the heart rate HRV signal. In 
order to explore the clinical value of HRV, the RR intervals 
were normalized with respect to the average RR interval, 
obtaining the normal-to-normal interval (NN). In this study 
fifteen time and frequency domain features were extracted 
from the NN and RR intervals. These features have been 
previously used for various purposes to quantify the HRV in 
term and preterm infants [5], [14]. 
The time domain features include the statistics of the RR 
interval distribution and include mean (meanRR), standard 
deviation (SDNN), skewness, kurtosis, triangular 
interpolation (TINN). 
Other features include the temporal information, such as 
root mean square of successive NN intervals (RMSSD) and 
the ratio between SDNN and RMSSD. The Poincare diagram 
is used to graphically describe beat-to-beat variability of the 
RR intervals and is constructed by plotting every RR interval 
against the preceding one. The main dimensions SD1 and 
SD2 of the Poincare diagram were used to quantify beat-to-
beat variations and a continuous shift in the RR interval. 
Nonlinear HRV features include approximate entropy 
(ApEn) to quantify regularity and complexity of stationary 
signal and the Allan Factor (AF) which quantifies the 
variability of successive counts. 
Frequency domain features were obtained from uniformly 
resampled NN intervals, at 256 Hz. HRV was then quantified 
by power various bands: very low frequency (0.008 – 0.04 
Hz) band (VLF); low frequency (0.04 – 0.2 Hz) band (LF),  
high frequency (0.2 - 1 Hz) band (HF) as well as the ratio 
between the LF and HF power (LF/HF) [5]. 
C. Statistical analysis: feature predictive power 
The area under the receiver operating characteristic curve 
(AUC) is used to quantify the discriminative (predictive) 
power of each HRV feature with respect to health status of 
preterm, which is represented by CCS. The AUC is directly 
connected to the Mann-Whitney U-statistics which is a robust 
non-parametric alternative to the student’s t-test. An area of 
0.5 indicates random discrimination, whereas the perfect 
discriminator has an AUC of 1. 
D. Boosted decision trees 
In order to check the discriminative capacity of a 
combination of HRV features the boosted decision tree 
classifier was used. Boosting is a method for the creation of 
an accurate and strong classifier from a set of weak classifiers 
[15] in a stage-wise fashion, by optimizing an arbitrary 
differentiable loss function. After a weak learner is trained, 
the data are then reweighted so that examples that were 
misclassified at the previous stage now gain weight and 
examples that are classified correctly lose weight. 
Given a set of N training examples of the form 
{(𝑥1, 𝑦1), … , (𝑥𝑁 , 𝑦𝑁)} such that 𝑥𝑖 is the feature vector of the 
i-th example and 𝑦𝑖  is its label, the goal is to teach a model, 
𝑓, to predict values in the form, ?̂? = ∑ 𝑓𝑘𝑘 (𝑥). At each stage 
of gradient boosting, 1 ≤ 𝑘 ≤ 𝐾, a model, 𝑓𝑘, is constructed. 
A new improved model is then constructed, 𝑓𝑘+1(𝑥), that adds 
an estimator, h to the previous model: 𝑓𝑘+1(𝑥) =  𝑓𝑘(𝑥) +
ℎ(𝑥), where h is fitted to the residuals, 𝑦 −  𝑓𝑘(𝑥). 
More formally, the following objective function is 
minimized: 
𝐿(𝜑) = ∑ 𝑙(𝑦?̂?, 𝑦𝑖)𝑖 + ∑ 𝛺(𝑓𝑘)𝑘 ,     (1) 
Here 𝑙 is a differentiable convex loss function that 
measures the difference between the prediction and the target. 
The second term 𝛺 penalizes the complexity of the regression 
tree functions. The regularization term helps to smooth the 
learnt weights to avoid over-fitting. 
The extreme gradient boosting classifier, XGBoost [16] is 
a well-known implementation of boosted decision trees and is 
widely used in machine learning community, e.g. in Kaggle 
competitions. The XGB classifier also allows for the retrieval 
of the importance of each feature as the accumulated gain 
which is achieved in construction of the ensemble of decision 
trees. 
The epochs of the physiological data are fed into the 
designed XGB classifier and the probabilities of abnormal 
outcome are returned for each epoch. The mean probability 
across the whole recording is then computed to represent the 
probability of the abnormal outcome – one value per baby. 
  
E. Model selection and performance assessment 
In this work the performance of the classifier was similarly 
measured by AUC. The leave-one-out (LOO) subject 
independent performance assessment is used in this work. All 
but one subject’s data were used for training and the 
remaining subject’s data were used for testing. The procedure 
was repeated until each patient had been a test subject. 
The user-tuneable parameters of the XGB classifier were 
selected using the 5 times 2-fold cross validation (CV) which 
was performed on the training data. CV folds were designed 
in a way that preserved the subject integrity. This allows for a 
model selection routine that has an optimization criteria that 
matches the one of the LOO performance assessment routine 
– subject-independent evaluation. 
III. RESULTS AND DISCUSSION 
The results of the predictive power of HRV are presented 
in Table I. The AUC was evaluated for different subsets of 
HRV features – using the whole recording or using only those 
segments where MAP < GA+4. 
It can be seen from Table I that epoch-based features bear 
moderate predictive power with respect to the outcome, with 
mean RR reaching an AUC of 0.82. Importantly, examining 
HRV during episodes of low blood pressure improves the 
predictive power of almost every HRV feature, with RMSSD 
achieving the highest discriminating power with an AUC of 
0.8 7, a substantial improvement from 0.76. 
It is worth noting that in both cases the same 23 preterms 
are used. Newborns without hypotensive episodes were 
excluded from the experiment as explained in Section II.A. 
This ensures that the two corpuses – original dataset and 
hypotensive events – are comparable and the improvement is 
purely attributable to the effect that BP has on HRV rather 
than an effect which could be caused by including extra 
subjects in the original dataset category (those newborns 
whose MAP ≥GA+4). 
Fig. 1 shows the probability density function of the 
RMSSD feature for the original dataset, the subset with 
normal BP and the subset of hypotensive events, for the 
cohort of preterms with both healthy and unhealthy outcomes. 
From Fig. 1 it can be seen that the HRV, in terms of the energy 
of the successive differences between neighbouring RR 
intervals, is generally higher for the healthy cohort than 
unhealthy for both the whole recording and for the episodes 
with normal BP, with a substantial overlap between the two 
distributions. From Fig. 1 (c) it can be seen that the separation 
increases when considering only hypotensive episodes. If we 
compare distributions of RMSSD for the cohort of preterms 
with the healthy outcome, for episodes with normal BP (Fig.1 
(b)) and low BP (Fig. 1 (c)), it can be seen that HRV increases 
with the decreased BP. At the same time, for the cohort with 
unhealthy outcome, the HRV stays the same regardless of the 
BP values. The healthier preterms react to the change in BP. 
In [17] the increased level of interaction between EEG and 
BP in preterms was shown to be associated with lower risks 
of illness severity. Similarly here as shown in Fig. 1, the 
increased “interaction” between HRV and BP is associated 
with good outcome, whereas the lack of response is associated 
with poor outcome. 
Fig. 2 shows the 3D projection of the principal component 
analysis applied to the set of all features on the original dataset 
and hypotensive subset. The PCA projection of the 
combination of the MeanRR and fourteen HRV features on 
TABLE I.  PREDICTIVE POWER OF HRV FEATURES MEASURED USING 
AUC. “ORIGINAL” REPRESENTS COMPLETE RECORDINGS FROM 23 
SUBJECTS. “HYPOTENSIVE EVENTS” REPRESENT ONLY EPOCHS WITH 
MAP<GA+4 FROM THE SAME 23 SUBJECTS. 
HRV features 
Original 
(6217 epochs ) 
Hypotensive 
events  
(1488 epochs) 
Δ 
VLF 0.67 0.7  
LF 0.76 0.78  
HF 0.64 0.76  
LF/HF 0.73 0.69  
MeanRR 0.82 0.85  
SDNN 0.65 0.73  
TINN 0.7 0.77  
Skewness 0.58 0.52  
Kurtosis 0.56 0.61  
ApEn 0.67 0.78  
SD1 0.52 0.54  
SD2 0.65 0.72  
RMSSD 0.76 0.87  
SDNN/RMSSD 0.64 0.65  
AllanFactor 0.51 0.55  
Δ represents an increase or decrease of the performance. 
 
(a)           (b)            (c) 
Figure 1. PDF for the RMSSD feature. Original subset (a) contains RMSSD feature values from the complete recordings. Normal (b) and hypotensive 
(c) subsets represent RMSSD feature extracted during episodes of normal BP (𝑀𝐴𝑃 ≥ 𝐺𝐴 + 4) and during hypotensive events (𝑀𝐴𝑃 < 𝐺𝐴 + 4). 
  
the original dataset results in no clear discrimination between 
healthy and unhealthy neonates whereas a clear separation is 
observable for the hypotensive subset when the features are 
combined. 
Feeding all fifteen features extracted for hypotensive 
subset into a boosted decision tree classifier further improved 
the performance, reaching an AUC of 0.97, in comparison to 
an AUC of 87% from the single best feature, RMSSD. This 
indicates that by using multimodal data, HRV and BP, an 
objective decision support tool for clinical prediction of short-
term outcome in preterms who suffer episodes of low BP can 
be built. The tool outputs a probability of good outcome for 
each 5 minute window and can guide and assist the healthcare 
professional in critical decision making. 
Fig. 3 plots the importance of the various features which is 
computed as a by-product of training the XGB classifier. The 
importance is computed as an average across 23 iterations in 
the LOO procedure. It can be seen that RMSSD and MeanRR 
are the two most important features for the short-term 
outcome prediction. RMSSD was previously shown to 
improve 2 year outcome prediction for preterm neonates [7]. 
MeanRR, a key time domain feature that is the inverse of the 
heart rate, is used for derivation of a number of HRV metrics. 
The boosted decision tree classifier has discovered that the 
combination of the heart rate and HRV is important for 
accurate prediction of the outcome. 
This is the first study which investigates an association 
between HRV and neonatal health outcome in the context of 
episodes of low BP. Obtained results indicate that HRV is 
sensitive to BP and features extracted during the episodes of 
low MAP improve the prediction of short-term outcome for 
the preterm neonates. ECG and BP records are usually 
available soon after birth and this work presents a promising 
step towards the use of multimodal data in building an 
objective decision support tool for the clinical prediction of 
short-term outcome in preterms who suffer from hypotension. 
Future research will concentrate on the incorporation of other 
modalities, such as EEG, for both short-term and long-term 
outcome prediction. 
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Figure 3. Mean of feature importance reported by the boosted decision 
trees classifier. 
 
  
(a)            (b)       
Figure 2. Principal component analysis (PCA) of the original dataset (a) and 
its hypotensive subset (MAP<GA+4) (b). In this study PCA is used as a tool 
for exploratory feature analysis aimed at checking the discriminative power 
of HRV features with respect to the short-term outcome of the preterm 
neonate. 
